A trial of an AI algorithm that uses retina images to evaluate the risk for atherosclerotic cardiovascular disease demonstrates a high level of accuracy. Medscape Medical News
Tag: News
Treating IgG4-RD: How Far Will B-Cell Drugs Take the Field?
Post hoc analyses of pivotal MITIGATE trial show broad efficacy across patient subgroups with differing organ involvement and clinical characteristics. Medscape Medical News
Docs, Lawsuit Challenge Medicare WISeR Prior Auth Experiment
Doctors in multiple states report unpaid claims and care delays under the new federal program, as a lawsuit seeks answers about AI algorithms and data security. Medscape Medical News
Myopia Numbers Are Rising. Our Response Should Be Too
With myopia affecting 1 in 3 people, eye experts are urging clinicians to act now to slow progression in patients. Medscape Medical News
Immunovant’s Treatment for Eye Disease Fails in Late-stage Trials
Immunovant said on Thursday that its therapy failed to reduce eye bulging when tested in patients with moderate-to-severe thyroid eye disease in two late-stage… Reuters Health Information
The Death of the Medical Fax Is Foretold — Again
Medical offices are sick and tired of faxing, and federal officials agree. But modernization won’t be easy. Medscape Medical News
Viridian Eye Disease Drug Disappoints on Efficacy Despite Trial Success
Viridian Therapeutics’ experimental treatment for thyroid eye disease lagged rivals in efficacy in a late-stage… Reuters Health Information
Kodiak Sciences Eye Drug Succeeds in Late-stage Study
Kodiak Sciences’ experimental drug met the main goal in a late-stage trial. Reuters Health Information
Floaters May Signal Urgent Need for Specialty Attention
The risk for retinal detachment is particularly strong in people with at least 10 floaters, Dutch researchers have found. Medscape Medical News
EyePoint Sues Rival Ocular Therapeutix, Alleging False Claims About Eye Drug
EyePoint filed a lawsuit on Friday accusing rival Ocular Therapeutix of spreading false or misleading information about EyePoint and its lead experimental eye… Reuters Health Information
Paralympic Classification: Making Milano Cortina Fair
For clinicians, knowing the B, LW, and SB class systems helps interpret outcomes and advise athletes on training, equipment choices, and realistic performance expectations. Medscape News Europe
Eye Condition Risk Elevated With Semaglutide, but Still Low
New VA database study is the latest to find a small but significant increased risk for nonarteritic anterior ischemic optic neuropathy. Medscape Medical News
FDA Withdraws Proposal to Prohibit Minors From Tanning Beds
‘Restricting teens’ access to indoor tanning and informing the public about the dangers of indoor tanning are critical to preventing skin cancer,’ AAD President Susan C. Taylor, MD, said. Medscape Medical News
US FDA Declines to Approve Aldeyra’s Eye Disorder Drug, Shares Slump
The U.S. Food and Drug Administration declined to approve Aldeyra Therapeutics’ drug for a type of eye disease, the company said on Tuesday, sending its shares plunging… Reuters Health Information
Change Healthcare Breach Still Affecting Docs, Hospitals
Physicians and hospitals alike are still digging out financially from the impact of the massive Change Healthcare hack in 2024. Medscape Medical News
Genomics and AI Will Up Precision of Glaucoma Care
Polygenic risk scores in development for glaucoma could usher in more personalized estimates of risk. Medscape Medical News
Cosmetic Eyelash Extensions Raise Eye Safety Concerns
Eyelash extensions may contribute to blepharitis, dry eye disease, and corneal injury through meibomian gland dysfunction. Medscape News Australia
Spanish Researchers Develop Low-cost Artificial Cornea From Fish Scales
Researchers at Spain’s University of Granada have developed an artificial cornea made from the scales of several fish species commonly found in markets, which could become… Reuters Health Information
Could Blood Pressure Meds Worsen Glaucoma Damage?
Patients with glaucoma who had low 24-hour systemic blood pressure were more likely to lose retinal nerve fiber layer despite well-controlled intraocular pressure. Medscape Medical News
Pediatric Rheumatologist Explains Updated ACR JIA Guidelines
The new draft guidelines favor earlier DMARD therapy with ‘much decreased reliance on glucocorticoids that have several side effects in growing children,’ said rheumatologist Susan Shenoi, MS. Medscape Medical News